WallStreetZenWallStreetZen

NASDAQ: DYN
Dyne Therapeutics Inc Stock Ownership - Who owns Dyne Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Dyne Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Wildon FarwellChief Medical Officer2024-03-121,030$25.58
$26.35kSell
Susanna Gatti HighChief Operating Officer2024-03-112,292$25.70
$58.90kSell
Joshua T. BrummCEO President2024-03-1140,072$25.42
$1.02MSell
Jonathan McNeillChief Business Officer2024-03-111,776$25.71
$45.66kSell
Jonathan McNeillChief Business Officer2024-03-1117,825$25.48
$454.18kSell
Jonathan McNeillChief Business Officer2024-03-1117,825$5.54
$98.75kBuy
Oxana BeskrovnayaChief Scientific Officer2024-03-112,081$25.70
$53.48kSell
Joshua T. BrummCEO President2024-03-1150,000$5.54
$277.00kBuy
Joshua T. BrummCEO President2024-03-119,928$26.10
$259.12kSell
Joshua T. BrummCEO President2024-03-117,769$26.12
$202.93kSell

1 of 19

DYN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DYN insiders and whales buy or sell their stock.

DYN Shareholders

What type of owners hold Dyne Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Atlas Venture Life Science Advisors LLC12.06%9,885,449$244.47MInstitution
Atlas Venture Fund Xi LP8.01%6,562,578$162.29MInsider
Forbion Capital Fund Iv Cooperatief Ua7.48%6,131,079$151.62MInsider
Fcpm Iii Services Bv7.48%6,131,079$151.62MInstitution
Jason P. Rhodes6.95%5,698,091$140.91MInsider
Mpm Asset Management LLC6.04%4,951,303$122.45MInstitution
Blackrock Inc4.62%3,788,682$93.69MInstitution
Citadel Advisors LLC3.73%3,053,440$75.51MInstitution
Vv Manager Ii LLC3.61%2,960,046$73.20MInsider
Ra Capital Management LP3.42%2,805,045$69.37MInsider

1 of 3

DYN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DYN65.80%34.20%Net SellingNet Selling
CLDX82.75%17.25%Net BuyingNet Buying
KYMR71.48%28.52%Net SellingNet Selling
NTLA68.92%31.08%Net SellingNet Selling
RCKT54.89%45.11%Net SellingNet Selling
View Top Biotech Stocks

Dyne Therapeutics Stock Ownership FAQ

Who owns Dyne Therapeutics?

Dyne Therapeutics (NASDAQ: DYN) is owned by 85.31% institutional shareholders, 44.34% Dyne Therapeutics insiders, and 0.00% retail investors. Atlas Venture Fund Xi LP is the largest individual Dyne Therapeutics shareholder, owning 6.56M shares representing 8.01% of the company. Atlas Venture Fund Xi LP's Dyne Therapeutics shares are currently valued at $162.29M.

If you're new to stock investing, here's how to buy Dyne Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.